(EMAILWIRE.COM, January 02, 2019 ) The global market for organ on a chip was valued at nearly $30 million in 2017. The small size of the market is mainly because the organ-on-chip market has not yet been fully commercialized. Companies in the market are still in the research and development phase, and organs on chips are being used by a limited number of end-users. However, the organ on chip market is expected to grow at a compound annual growth rate (CAGR) of an astonishing 70% to reach more than $300 million by 2021.
Order report at
http://www.thebusinessresearchcompany.com/report/organ-on-chip-global-market-opportunities-and-strategies-to-2021
The organs on chips market is segmented into the following segments- Lung-On-Chip, Heart-On-Chip, Liver-On-Chip, Intestine-On-Chip, Kidney-On-Chip, Skin-On-Chip, Blood-Brain-Barrier-On-Chip, and Other Organ Models, out of which more than 50% of the global organ on a chip market is currently contributed by organ models for lung, kidney, intestine, heart and liver. The emphasis on lungs-on-chips, hearts-on-chips and livers-on-chips reflects the pharmaceutical companies spend on drug development in these areas.
Organ on a chip technology offers tremendous potential for predicting side effects and efficacy and potentially hugely decreasing the cost of drug testing. Microarray market and lab-on-a-chip market is the leading trend changer for the biochip market.
Download sample report for free at:
http://www.thebusinessresearchcompany.com/sample.aspx?id=805&type=smp
The lung-on-chip segment is one of the most commercially used organ models. It constituted 20% of the global organ on chip market in 2017. Lung-on-chip is mainly used to study airway closure and opening, lung inflammation, airway protein synthesis or pulmonary absorption. This segment was followed by heart-on-chip, which constituted about 12% of the global organ on chip market in 2017. The heart-on-chip model is used for measuring the stresses, electrophysiology and cellular architecture of the heart.
Pharmaceutical companies are primarily using organ on a chip in drug development process, to understand how drugs are processed by humans and compare human models with animal models.
About The Business Research Company.
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Linkedin: http://in.linkedin.com/company/the-business-research-company
Marketing TBRC
+91 8897263534
Marketing@tbrc.info
Source: EmailWire.Com 
